Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Innovative Eyewear, Inc.

LUCYNASDAQ
Healthcare
Medical - Instruments & Supplies
$1.14
$0.01(1.33%)
U.S. Market opens in 17h 9m

Innovative Eyewear, Inc. Fundamental Analysis

Innovative Eyewear, Inc. (LUCY) shows moderate financial fundamentals with a PE ratio of -0.70, profit margin of -3.28%, and ROE of -0.31%. The company generates $0.0B in annual revenue with strong year-over-year growth of 41.99%.

Key Strengths

Cash Position131015.86%
PEG Ratio-13.76
Current Ratio11.98

Areas of Concern

ROE-0.31%
Operating Margin-3.41%
We analyze LUCY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -198.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-198.7/100

We analyze LUCY's fundamental strength across five key dimensions:

Efficiency Score

Weak

LUCY struggles to generate sufficient returns from assets.

ROA > 10%
-0.07%

Valuation Score

Excellent

LUCY trades at attractive valuation levels.

PE < 25
-0.70
PEG Ratio < 2
-13.76

Growth Score

Excellent

LUCY delivers strong and consistent growth momentum.

Revenue Growth > 5%
41.99%
EPS Growth > 10%
59.04%

Financial Health Score

Excellent

LUCY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
11.98

Profitability Score

Weak

LUCY struggles to sustain strong margins.

ROE > 15%
-30.54%
Net Margin ≥ 15%
-3.28%
Positive Free Cash Flow
No

Key Financial Metrics

Is LUCY Expensive or Cheap?

P/E Ratio

LUCY trades at -0.70 times earnings. This suggests potential undervaluation.

-0.70

PEG Ratio

When adjusting for growth, LUCY's PEG of -13.76 indicates potential undervaluation.

-13.76

Price to Book

The market values Innovative Eyewear, Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -840.26 times EBITDA. This is generally considered low.

-840.26

How Well Does LUCY Make Money?

Net Profit Margin

For every $100 in sales, Innovative Eyewear, Inc. keeps $-3.28 as profit after all expenses.

-3.28%

Operating Margin

Core operations generate -3.41 in profit for every $100 in revenue, before interest and taxes.

-3.41%

ROE

Management delivers $-0.31 in profit for every $100 of shareholder equity.

-0.31%

ROA

Innovative Eyewear, Inc. generates $-0.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Innovative Eyewear, Inc. generates limited operating cash flow of $-7.39M, signaling weaker underlying cash strength.

$-7.39M

Free Cash Flow

Innovative Eyewear, Inc. generates weak or negative free cash flow of $-7.49M, restricting financial flexibility.

$-7.49M

FCF Per Share

Each share generates $-1.64 in free cash annually.

$-1.64

FCF Yield

LUCY converts -1.53% of its market value into free cash.

-1.53%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.70

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-13.76

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.001

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.17

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

11.98

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How LUCY Stacks Against Its Sector Peers

MetricLUCY ValueSector AveragePerformance
P/E Ratio-0.7029.43 Better (Cheaper)
ROE-0.31%800.00% Weak
Net Margin-327.98%-20145.00% (disorted) Weak
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio11.984.64 Strong Liquidity
ROA-0.07%-17936.00% (disorted) Weak

LUCY outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Innovative Eyewear, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

2155.92%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-96.54%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ